4.6 Article

The Human Papillomavirus E7 Proteins Associate with p190RhoGAP and Alter Its Function

期刊

JOURNAL OF VIROLOGY
卷 88, 期 7, 页码 3653-3663

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.03263-13

关键词

-

类别

资金

  1. Canadian Institute of Health Research
  2. Canadian Institute of Health Research Michael Smith Foreign Study Supplement
  3. Ontario Graduate Scholarship

向作者/读者索取更多资源

Using mass spectrometry, we identified p190RhoGAP (p190) as a binding partner of human papillomavirus 16 (HPV16) E7. p190 belongs to the GTPase activating protein (GAP) family and is one of the primary GAPs for RhoA. GAPs stimulate the intrinsic GTPase activity of the Rho proteins, leading to Rho inactivation and influencing numerous biological processes. RhoA is one of the best-characterized Rho proteins and is specifically involved in formation of focal adhesions and stress fibers, thereby regulating cell migration and cell spreading. Since this is the first report that E7 associates with p190, we carried out detailed interaction studies. We show that E7 proteins from other HPV types also bind p190. Furthermore, we found that conserved region 3 (CR3) of E7 and the middle domain of p190 are important for this interaction. More specifically, we identified two residues in CR3 of E7 that are necessary for p190 binding and used mutants of E7 with mutations of these residues to determine the biological consequences of the E7-p190 interaction. Our data suggest that the interaction of E7 with p190 dysregulates this GAP and alters the actin cytoskeleton. We also found that this interaction negatively regulates cell spreading on a fibronectin substrate and therefore likely contributes to important aspects of the HPV life cycle or HPV-induced tumorigenesis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Otorhinolaryngology

Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancer

Hugh A. J. Kim, Peter Y. F. Zeng, Alana Sorgini, Mushfiq H. Shaikh, Halema Khan, Danielle MacNeil, Mohammed Khan, Adrian Mendez, John Yoo, Kevin Fung, Pencilla Lang, David A. Palma, Joe S. Mymryk, John W. Barrett, Krupal B. Patel, Paul C. Boutros, Anthony C. Nichols

Summary: Numerous studies have shown that head and neck squamous cell carcinoma (HNSCC) outcomes differ among different races and ethnicities. This study found that Black patients with non-HPV-related tumors had poorer progression-free survival compared to White patients. The tumors of Black patients exhibited molecular differences, including copy number aberrations, methylation of SFRP1, and miRNA-mediated PRG4 silencing, which were associated with poor survival. These findings can help inform targeted treatment decisions to achieve equitable outcomes.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2022)

Article Otorhinolaryngology

The prevalence of human papillomavirus in paediatric tonsils in Southwestern Ontario

M. Wojtera, J. W. Barrett, J. E. Strychowsky, A. Dzioba, J. Paradis, M. Husein, M. Salvadori, A. C. Nichols

Summary: No human papillomavirus subtypes 6, 11, 16 or 18 were found in paediatric tonsil specimens from Southwestern Ontario.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2022)

Article Otorhinolaryngology

Introduction and expression of PIK3CAE545K in a papillary thyroid cancer BRAFV600E cell line leads to a dedifferentiated aggressive phenotype

Nicole Pinto, Kara M. Ruicci, Mohammed Imran Khan, Mushfiq Hassan Shaikh, Yu Fan Peter Zeng, John Yoo, Kevin Fung, S. Danielle MacNeil, Adrian Mendez, Joe S. Mymryk, John W. Barrett, Paul C. Boutros, Anthony C. Nichols

Summary: This study provides evidence of the role of PIK3CA(E545K) in driving disease progression from a well-differentiated to an undifferentiated thyroid cancer, but over-expression is not a determinant of an accelerated growth phenotype in ATC.

JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2022)

Review Oncology

Validity of functional patient-reported outcomes in head and neck oncology: A systematic review

Adrian Mendez, Jacob G. J. Wihlidal, Dean T. Eurich, Anthony C. Nichols, S. Danielle MacNeil, Hadi R. Seikaly

Summary: Malignancy and treatment effects in head and neck oncology can have devastating impacts on functional aspects of patient life, such as swallowing, speech, dry mouth, and chewing. Patient-Reported Outcomes (PROs) have become the gold standard for assessing subjective functional outcomes, but few have incorporated extensive patient input in their development process. More efforts are needed to involve head and neck cancer patients in PRO development, particularly in the domains of speech and chewing.

ORAL ONCOLOGY (2022)

Article Dentistry, Oral Surgery & Medicine

Variations of the thoracodorsal axis: application for scapular tip free flap harvesting

Axel Sahovaler, Hubert Low, Francisco Laxague, Eun-Jae Chung, Kevin Fung, S. Danielle Mac Neil, Anthony C. Nichols, John Yoo

Summary: The study reviewed 40 patients who underwent scapular tip free flap reconstruction and found significant variations in the subscapular vascular anatomy, which have important implications for surgical access and patient positioning.

ORAL AND MAXILLOFACIAL SURGERY-HEIDELBERG (2022)

Article Otorhinolaryngology

Establishment of four head and neck squamous cell carcinoma cell lines: importance of reference DNA for accurate genomic characterisation

K. B. Patel, S. Prokopec, J. W. Barrett, J. S. Mymryk, P. C. Boutros, A. C. Nichols

Summary: This study aimed to establish early passage cell lines with matched normal reference DNA for precision medicine in drug response evaluation. It successfully established early passage cell lines and confirmed their association with the primary tumor through short tandem repeat profiling. The study highlights the importance of matched normal reference DNA for accurate mutational analysis in cell lines.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2023)

Article Medicine, Research & Experimental

Risk Factors for Poor Survival Outcomes in Parotid Metastatic Cutaneous Squamous Cell Carcinoma

Francisco Laxague, Agnieszka Dzioba, Dhruv Jasani, Andrew Warner, David A. Palma, Pencilla Lang, Varagur Venkatesan, Nancy Read, Anthony C. Nichols, Kevin Fung, John Yoo, Adrian Mendez, Danielle MacNeil

Summary: This study analyzed risk factors associated with poor survival outcomes for metastatic cutaneous head-and-neck squamous cell carcinoma (SCC) to the parotid gland. The results showed that a shorter duration of adjuvant radiation therapy (RT) and excised tumor volume >= 50 cm(3) were predictive factors of reduced overall survival (OS) and disease-specific survival (DSS). A shorter duration of RT was also associated with reduced freedom from locoregional recurrence (LRR).

LARYNGOSCOPE (2023)

Article Otorhinolaryngology

Surgical margins of the oral cavity: is 5 mm really necessary?

James Fowler, Yael Campanile, Andrew Warner, Francisco Laxague, Naif Fnais, Kevin Fung, Adrian Mendez, Danielle MacNeil, John Yoo, David Palma, Anthony Nichols

Summary: The study found that in head and neck surgery, patients with margins greater than 1 mm had similar local recurrence and overall survival rates compared to patients with margins greater than 5 mm, while patients with margins less than 1 mm showed worse survival outcomes.

JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2022)

Article Otorhinolaryngology

Demographic and pathologic factor regression to a growth rate model of p16-negative oral cavity squamous cell carcinoma

Jacob G. J. Wihlidal, Keng Yeow Tay, S. Danielle MacNeil, Anthony C. Nichols, Kevin Fung, John H. J. Yoo, Adrian Mendez

Summary: The objective of this study was to quantify the growth rate of p16-negative oral cavity squamous cell carcinoma, explore the causative relationships between demographic risk factors and tumor growth, and examine pathologic findings associated with the tumor growth rate. Results from a small prospective cohort sample suggest clinical associations between alcohol consumption, origination at the retromolar trigone, and clinical nodal stage with rate of tumor growth.

LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY (2022)

Article Oncology

External validation of a CT-based radiomics signature in oropharyngeal cancer: Assessing sources of variation

Philipp Guevorguian, Tricia Chinnery, Pencilla Lang, Anthony Nichols, Sarah A. Mattonen

Summary: This study validated a radiomics model for risk stratification in oropharyngeal cancer, which showed comparable performance to the clinical model and outperformed when combined with clinical data. Additionally, a model for detecting dental artifacts on computed tomography images was also validated.

RADIOTHERAPY AND ONCOLOGY (2023)

Article Otorhinolaryngology

Association of Primary Tumor Volume With Survival in Patients With T3 Glottic Cancer Treated With Radiotherapy A Study of the Canadian Head & Neck Collaborative Research Initiative

Nauman H. Malik, Rui Fu, Nicolin Hainc, Christopher W. Noel, John R. de Almeida, Ali Hosni, Shao Hui Huang, Eugene Yu, Agnieszka Dzioba, Andrew Leung, Arvindpaul Mangat, Danielle MacNeil, Anthony C. Nichols, Shivaprakash B. Hiremath, Santanu Chakraborty, Alboorz Jooya, Marc Gaudet, Stephanie Johnson-Obaseki, Jonathan Whelan, Reza Forghani, Michael P. Hier, Gregoire Morand, Khalil Sultanem, Joseph Dort, John Lysack, Wayne Matthews, Steven Nakoneshny, Gia Gill, Adam Globerman, Paul Kerr, Pejman Maralani, Irene Karam, Antoine Eskander

Summary: This study aimed to evaluate the association between primary tumor volume and oncologic outcomes in patients with T3 glottic cancer treated with (chemo)radiotherapy. The study found that increasing tumor volume was associated with worse overall survival and disease-free survival in these patients.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2023)

Review Oncology

Lenvatinib in multimodal therapy for unresectable radioactive iodine-naive differentiated thyroid cancer: A case report with literature review

Hugh Andrew Jinwook Kim, Anthony Charles Nichols, Ramanamurthy Rachakonda, Richard Inculet, Jinka Sathya, Irina Rachinsky, Eric Winquist

Summary: This article reports a case of unresectable or metastatic differentiated thyroid carcinoma treated with lenvatinib and external beam radiation therapy. The patient showed clinical, biochemical, and radiological response after 5 months of lenvatinib and subsequently received external beam radiation. 21 months post-initiation of treatment, the patient enjoys good quality of life without evidence of cancer progression.

CANCER REPORTS (2022)

Article Oncology

Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial

Anthony C. Nichols, Julie Theurer, Eitan Prisman, Nancy Read, Eric Berthelet, Eric Tran, Kevin Fung, John R. de Almeida, Andrew Bayley, David P. Goldstein, Michael Hier, Khalil Sultanem, Keith Richardson, Alex Mlynarek, Suren Krishnan, Hien Le, John Yoo, S. Danielle MacNeil, Eric Winquist, J. Alex Hammond, Varagur Venkatesan, Sara Kuruvilla, Andrew Warner, Sylvia Mitchell, Jeff Chen, Martin Corsten, Stephanie Johnson-Obaseki, Michael Odell, Christina Parker, Bret Wehrli, Keith Kwan, David A. Palma

Summary: The study found that for early-stage OPSCC, radiotherapy performed better in terms of long-term swallowing quality of life compared to transoral robotic surgery plus neck dissection, although this difference decreases over time. Some differences in QOL concerns gradually resolved in the long term, but it is worth noting that TORS patients started using more nutritional supplements at 3 years, and dry mouth scores increased over time in RT patients.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Review Health Policy & Services

A Review of Health Care Disparities in Head and Neck Squamous Cell Carcinomas

Sepehr Shabani, Kea Turner, Anthony C. Nichols, Xuefeng Wang, Krupal B. Patel

Summary: This article discusses the health care disparities in head and neck squamous cell carcinomas, particularly focusing on racial differences. It highlights that African American patients are diagnosed at a younger age, present with higher tumor burden, receive less definitive cancer treatment, and have increased mortality compared to non-African American patients. The article suggests that these disparities can be eliminated through education, screening programs, and expanding health care coverage.

JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED (2022)

暂无数据